First Tracks Biotherapeutics, INC 10-Q quarterly reports
Quarterly reports, with unaudited financial statements and management’s discussion of the quarter just ended.
NASDAQ
First Tracks Biotherapeutics, Inc. reported its financial results for the second quarter ended June 30, 2026, highlighting continued investment in R&D and progress in clinical trials, alongside a significant net loss.